Evidence map›Paper›PMID 39128142›Full record

ReviewAutonomic neuroscience : basic & clinical2024

Renal interoception in health and disease.

Louise C Evans, Brianna Dailey-Krempel, Mariana R Lauar, Alex Dayton, Lucy Vulchanova, John W Osborn

Abstract readReview
In one paragraph

Review in Autonomic neuroscience : basic & clinical, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Neuroimmune Control of Inflammation in Acute Kidney Injury and Multiorgan Dysfunction.Journal of the American Society of Nephrology : JASN · 2025
    Review
  3. Renal interoception: form, function, and open questions.Current opinion in neurobiology · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Louise C EvansDepartment of Surgery, University of Minnesota Medical School, Minneapolis 55455, United States of America.
Brianna Dailey-KrempelDepartment of Neuroscience, University of Minnesota, Minneapolis 55455, United States of America.
Mariana R LauarDepartment of Surgery, University of Minnesota Medical School, Minneapolis 55455, United States of America.
Alex DaytonDivision of Nephrology and Hypertension, University of Minnesota Medical School, Minneapolis 55455, United States of America.
Lucy VulchanovaDepartment of Neuroscience, University of Minnesota, Minneapolis 55455, United States of America.
John W OsbornDepartment of Surgery, University of Minnesota Medical School, Minneapolis 55455, United States of America. Electronic address: osbor003@umn.edu.

Funding

Targeted Sympathetic Ablation for Treatment of HypertensionR01HL116476 · NHLBI · UNIVERSITY OF MINNESOTA · PI OSBORN, JOHN W · 2014 to 2022
$3.9M
Training Program in Cardiac InnovationT32HL144472 · NHLBI · UNIVERSITY OF MINNESOTA · PI Peter A Crawford, SAMUEL C DUDLEY · 2019 to 2026
$2.6M
Role of pressure induced renal inflammation in salt-sensitive hypertensionR01HL152166 · NHLBI · UNIVERSITY OF MINNESOTA · PI EVANS, LOUISE CHRISTINE · 2020 to 2024
$1.9M
Renal Afferent Nerve Circuitry and Pathogenesis on Blood Pressure RegulationF31DK139599 · NIDDK · UNIVERSITY OF MINNESOTA · PI DAILEY-KREMPEL, BRIANNA · 2024 to 2025
$76k
NHLBI NIH HHS R01 HL116476NHLBI NIH HHS R01 HL152166NHLBI NIH HHS T32 HL144472NIDDK NIH HHS F31 DK139599
6 · The paper itself

Abstract

Catheter based renal denervation has recently been FDA approved for the treatment of hypertension. Traditionally, the anti-hypertensive effects of renal denervation have been attributed to the ablation of the efferent sympathetic renal nerves. In recent years the role of the afferent sensory renal nerves in the regulation of blood pressure has received increased attention. In addition, afferent renal denervation is associated with reductions in sympathetic nervous system activity. This suggests that reductions in sympathetic drive to organs other than the kidney may contribute to the non-renal beneficial effects observed in clinical trials of catheter based renal denervation. In this review we will provide an overview of the role of the afferent renal nerves in the regulation of renal function and the development of pathophysiologies, both renal and non-renal. We will also describe the central projections of the afferent renal nerves, to give context to the responses seen following their ablation and activation. Finally, we will discuss the emerging role of the kidney as an interoceptive organ. We will describe the potential role of the kidney in the regulation of interoceptive sensitivity and in this context, speculate on the possible pathological consequences of altered renal function.

Indexed as

InteroceptionKidneyAfferent PathwaysAnimalsBlood PressureHumansHypertensionKidney DiseasesSympathetic Nervous SystemInteroceptionRenal afferent nerves

Identifiers

PMID39128142
PMCPMC12262828

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.